Redaelli B, Sforzini S, Bonoldi G, Dadone C, Di Filippo G, Filoramo F, Limido D, Mimmo R, Pincella G, Viganò M R
Int J Artif Organs. 1979 May;2(3):133-40.
This investigation was undertaken to define the "adequate" sodium concentration in the dialytic fluid allowing to maintain a stable plasma effective osmolality during dialysis. Isonatric dialysate is shown to miss this aim by inducing a predictable postdialytic hypernatremia. To avoid this effect a new approach was made. 17 clinically stabilized patients, previously dialyzed over a period of at least 2 years with a dialysate sodium concentration of 133 mEq/l, underwent dialysis with the "adequate" sodium concentration in the dialysate for over 3 years. During dialysis cramps, headache, hypotension, hypertensive crises and postdialytic weakness were reduced in frequency and nearly disappeared. No deterioration in blood pressure control occurred and improvement in some general parameters (hematocrit, glucose and insulin metabolism, well-being) was reported after prolonged treatment.
本研究旨在确定透析液中的“合适”钠浓度,以在透析期间维持稳定的血浆有效渗透压。结果表明,等钠透析液会导致可预测的透析后高钠血症,从而无法实现这一目标。为避免这种影响,我们采用了一种新方法。17例临床病情稳定的患者,此前使用钠浓度为133 mEq/l的透析液进行了至少2年的透析,之后使用“合适”钠浓度的透析液进行了3年多的透析。透析期间,痉挛、头痛、低血压、高血压危象和透析后虚弱的发生频率降低,几乎消失。血压控制没有恶化,长期治疗后一些一般参数(血细胞比容、葡萄糖和胰岛素代谢、健康状况)有所改善。